Thrombopoietin/MPL participates in initiating and maintaining RUNX1-ETO acute myeloid leukemia via PI3K/AKT signaling

Oncogenic mutations in components of cytokine signaling pathways elicit ligand-independent activation of downstream signaling, enhancing proliferation and survival in acute myeloid leukemia (AML). The myeloproliferative leukemia virus oncogene, MPL, a homodimeric receptor activated by thrombopoietin...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Pulikkan, John Anto, Madera, Dmitri, Xue, Liting, Bradley, Paul, Landrette, Sean Francis, Kuo, Ya-Huei, Abbas, Saman, Zhu, Lihua Julie, Valk, Peter, Castilla, Lucio Hernán
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Hematology 2012
Konular:
Myeloid Neoplasia
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3412349/
https://ncbi.nlm.nih.gov/pubmed/22613795
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2012-03-414649
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller